The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase

Chemistry and Biology

Volumn 4, Issue 6, 1997, Pages 423-431

  Wilson, Keith P ^a   McCaffrey, Patricia G ^a   Hsiao, Kathy ^a   Pazhanisamy, Sam ^a   Galullo, Vincent ^a   Bemis, Guy W ^a   Fitzgibbon, Matthew J ^a   Caron, Paul R ^a   Murcko, Mark A ^a   Su, Michael S S ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

IL 1; p38 MAP kinase; Pyridinylimidazole inhibitor; TNF; X ray structure

Indexed keywords

ANIMALIA;

EID: 12644277392     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90194-0     Document Type: Article

References (38)

1. Davis, R.J. (1995). Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42, 459-467.
2. Cobb, M.H. & Goldsmith, E.J. (1995). How MAP kinases are regulated. J. Biol. Chem. 270, 14843-14846.
3. Bokemeyer, D., Sorokin, A. & Dunn, M.J. (1996). Multiple intracellular MAP kinase signaling cascades. Kidney Int. 49, 1187-1198.
4. Derijard, B., et al., & Davis, R.J. (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
5. Man, J., Lee, J.D., Bibbs, L. & Ulevitch, R.J. (1994). A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811.
6. Raingeaud, J., et al., & Davis, R.J. (1995). Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426.
7. Shapiro, L. & Dinarello, C.A., (1995). Osmotic regulation of cytokine synthesis in vitro. Proc. Natl Acad. Sci. USA 92, 12230-12234.
8. Derijard, B., et al., & Davis, R.J. (1995). Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267, 682-685.
9. Man, J., Lee, J.-D., Jiang, Y., Li, Z., Feng, L. & Ulevitch, R.J. (1996). Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 271, 2886-2891.
10. Raingeaud, J., Whitmarsh, A.J., Barrett, T., Derijard, B. & Davis, R.J. (1996). MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16, 1247-1265.
11. Lee, J.C., et al., & Young, P.R. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.
12. Cuenda, A., et al., & Lee, J.C. (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233.
13. Cuenda, A., Cohen, P., Buee-Scherrer, V. & Goedert, M. (1997). Activation of stress-activated protein kinase 3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16, 295-305.
14. Badger, A.M., et al., & Griswold, D.E. (1996). Pharmacologic profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharm. Exp. Therapeut. 279, 1453-1461.
15. Saklatvala, J., et al., & Farndale, R.W. (1996). Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen of a thromboxane analogue. J. Biol. Chem. 271, 6586-6589.
16. Young, P.R., McDonnell, P., Dennington, D., Hand, A., Laydon, J. & Lee, J.C. (1993). Bicyclic imidazoles inhibit IL-I and TNF production at the protein level. Agents Actions 39, C67-C69.
17. Wang, X., & Ron, D. (1996). Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 272, 1347-1349.
18. Han, J., Jiang, Y., Li, Z., Kravchenko, V.V. & Ulevitch, R.J. (1997). Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386, 296-299.
19. Rouse, J., et al., & Nebreda, A.R. (1994). A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78, 1027-1037.
20. McLaughlin, M.M., et al., & Young, P.R. (1996). Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J. Biol. Chem. 271 (14) 8488-8492.
21. Guan, Z., Baier, L.D. & Morrison, A.R. (1997). p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by Interleukin-1β. J. Biol. Chem. 272, 8083-8089.
22. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. & Greenberg, M.E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
23. Wilson, K.P, et al., & Su, M.S.S. (1996). Crystal structure of p38 mitogen-activated protein kinase. J. Biol. Chem. 271, 27696-27700.
24. Wang, Z., Harkins, P.C., Ulevitch, R.J., Han, J., Cobb, M.H. & Goldsmith, E.J. (1997). The structure of mitogen-activated protein kinase p38 at 2.1 Å resolution. Proc. Natl. Acad. Sci. USA 94, 2327-2332.
25. Zhang, F., Strand, A., Robbins, D., Cobb, M.H. & Goldsmith, E.J. (1994). Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature 367, 704-711.
26. Gallagher, T.F., et al., & Adams, J.L. (1997). Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase. Bioorg. Med. Chem. 5, 49-64.
27. Li, Z., Jiang, V., Ulevitch, R.J. & Han, J. (1996). The primary structure of p38 gamma: a new member of the p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228, 334-340.
28. Mertens, S., Craxton, M. & Goedert, M. (1996). SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS Lett 383, 273-276.
29. Johnson, L.N., Noble, M.E.M. & Owen, D.J. (1996). Active and inactive protein kinases: structural basis for regulation. Cell 85, 149-158.
30. Doza, Y.N., Cuenda, A., Thomas, G.M., Cohen, P. & Nebreda, A.R. (1995). Activation of the MAP kinase homologue RK requires the phosphorylation of Thr180 and Tyr182 and both residues are phosphorylated in chemically stressed KB cells. FEBS Lett. 364, 223-228.
31. Gallagher, T.F., et al., & Adams, J.L. (1995). 2,4,5-triarylimidazole inhibitors of IL-1 biosynthesis. Bioorg. Med. Chem. Lett. 5, 1171-1176.
32. Boehm, J.C., et al., & Adams, J.L. (1996). 1-Substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency. J. Med. Chem. 39, 3929-3937.
33. Van Leusen, A.M, Wildeman, J. & Oldenziel, O.H. (1977). Base-induced cycloaddition of sulfonylmethyl isocyanides to C,N double bonds. Synthesis of 1,5-disubstituted and 1,4,5-trisubstituted imidazoles from aldimines and imidoyl chlorides. J. Org. Chem. 42, 1153-1159.
34. Adams, Sheldiake, Gallagher, Garigipati; SmithKline Beecham US 08092,733 (CIP); International Publication Number: WO 95/02591.
35. Mach, R.H., et. al., & Evora, P.M. (1993). 18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography. J. Med. Chem. 36, 3707-3719.
36. Otwinowski, Z., & Minor, W. (1996). Processing of X-ray diffraction data collected in oscillation mode. In Methods in Enzymology (Carter, C.W. & Sweet, R.M., Eds), Academic Press. New York, USA.
37. Brünger, A.T. (1992). XPLOR: A System for X-ray Crystallography and NMR. (Yale University Press, New Haven, CT, USA) Version 3.1.
38. Burkert, U. & Allinger, N.L. (1982) In Molecular Mechanics, American Chemical Society Monograph No. 177, ACS Press, Washington, DC, USA.